Xiaoxing Feng

A Phase 1 study of ADI‐PEG20 (pegargiminase) combined with cisplatin and pemetrexed in ASS1‐negative metastatic uveal melanoma

P. Szlosarek, J. Bomalaski, M. Sheaff, 2022, Pigment cell & melanoma research.

Phase 1b study of pegylated arginine deiminase (ADI-PEG 20) plus Pembrolizumab in advanced solid cancers

Jianjun Gao, J. Blando, P. Szlosarek, 2021, Oncoimmunology.

A phase 1/1B trial of ADI‐PEG 20 plus nab‐paclitaxel and gemcitabine in patients with advanced pancreatic adenocarcinoma

G. Abou-Alfa, J. Harding, M. Lowery, 2017, Cancer.

Phase I study of ADI‐PEG20 plus low‐dose cytarabine for the treatment of acute myeloid leukemia

J. Bomalaski, H. Hsiao, Tsai-Yun Chen, 2021, Cancer medicine.

A Phase I Study of Pegylated Arginine Deiminase (Pegargiminase), Cisplatin, and Pemetrexed in Argininosuccinate Synthetase 1-Deficient Recurrent High-grade Glioma

T. Crook, P. Szlosarek, R. Jena, 2019, Clinical Cancer Research.

Phase 1 Dose-Escalation Study of Pegylated Arginine Deiminase, Cisplatin, and Pemetrexed in Patients With Argininosuccinate Synthetase 1–Deficient Thoracic Cancers

G. Cook, P. Szlosarek, J. Spicer, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase 1, pharmacogenomic, dose‐expansion study of pegargiminase plus pemetrexed and cisplatin in patients with ASS1‐deficient non‐squamous non‐small cell lung cancer

P. Szlosarek, J. Bomalaski, M. Sheaff, 2021, Cancer medicine.

Expansion Phase 1 Study of Pegargiminase Plus Pemetrexed and Cisplatin in Patients With Argininosuccinate Synthetase 1–Deficient Mesothelioma: Safety, Efficacy, and Resistance Mechanisms

J. Shamash, P. Szlosarek, J. Spicer, 2020, JTO clinical and research reports.

TITLE: A Phase I study of pegylated arginine deiminase (pegargiminase), cisplatin and pemetrexed in argininosuccinate synthetase 1-deficient recurrent high-grade glioma

T. Crook, P. Szlosarek, R. Jena, 2019 .

A phase 1 study of ADI-PEG 20 and modified FOLFOX6 in patients with advanced hepatocellular carcinoma and other gastrointestinal malignancies

G. Abou-Alfa, J. Harding, Chien-Feng Li, 2018, Cancer Chemotherapy and Pharmacology.

Phase 1 study of pegargiminase combined with cisplatin and pemetrexed in patients with ASS1-deficient uveal melanoma.

P. Szlosarek, J. Bomalaski, M. Sheaff, 2018 .